Related Experiment Video
Updated: Aug 23, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Parasite cyclophilins and antiparasite activity of cyclosporin A
A P Page1, S Kumar, C K Carlow
1Wellcome Unit for Molecular Parasitology, University of Glasgow, UK.
Abstract:
Cyclosporin A (CsA) was initially developed as an immunosuppressive drug. In the past several years, it has been shown to possess antiparasite activity independent of the immune system. It is not known how the drug exerts these antiparasite effects, or why it is stage and/or species specific. The answers may lie in the enzymatic function of cyclophilins. The cyclophilins are a growing family of proteins that exhibit peptidyl-prolyl cis-trans isomerase (PPiase) activity and bid CsA to varying degrees. PPiases have been shown to play a role in the folding of many essential proteins. Antony Page, Sanjay Kumar and Clotilde Carlow here review parasite cyclophilins and their association with CsA. The possible biological function of parasite cyclophilins and their potential role in future drug discovery are also discussed.
Related Concept Videos
Microbial Interactions: Parasitism
Anthelminthic Agents
Antiprotozoal Agents
Fungal Phylum Microsporidia
Diversity of Protists II
Antifungal Agents
